Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues.

Ligand-activated Cre recombinases are widely used for studying gene function in vitro and in conditional mouse models. To compare ligand-dependent Cre recombinases, different Cre estrogen receptor fusions were introduced into the ROSA26 locus of embryonic stem (ES) cells and assayed for genotoxicity and recombination efficiency. Of the tested recombinases, the CreERT2 variant showed no toxicity and was highly responsive to ligand induction. To constitutively express CreERT2 in mice and also to clarify whether the CreERT2 system displays background activity, we generated a knock-in mouse line harboring the CreERT2 coding region under the control of the ROSA26 locus. Analysis of this ROSA26-CreERT2 deleter mouse with different reporter strains revealed ubiquitous recombination in the embryo and partial recombination in peripheral and hematopoietic tissues but no effective CreERT2 expression in the brain. Furthermore, using flow cytometry, we found low-level background recombination in noninduced bitransgenic ROSA26-CreERT2/EGFP reporter mice. To determine whether background activity poses a general problem for conducting conditional in vivo experiments with the ROSA26-CreERT2 deleter, we used a sensitive conditional skin cancer model. In this assay, cancer induction was completely restricted to induced bitransgenic CreERT2/K-Ras(V12) mice, whereas noninduced control animals did not show any sign of cancer, indicating the usefulness of the ROSA-CreERT2 system for regulating conditional gene expression in vivo. The ROSA26-CreERT2 deleter strain will be a convenient experimental tool for studying gene function under circumstances requiring partial induction of recombination in peripheral tissues and will be useful for uncovering previously unknown or unsuspected phenotypes.

[1]  R. Hoess,et al.  Evidence for a second conserved arginine residue in the integrase family of recombination proteins. , 1992, Protein engineering.

[2]  Rainer Constien,et al.  Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line , 2001, Genesis.

[3]  A. Berns,et al.  Requirement for a functional Rb-1 gene in murine development , 1992, Nature.

[4]  S. Linn,et al.  Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene , 2001, Oncogene.

[5]  P Chambon,et al.  Ligand-activated site-specific recombination in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Begley Cg,et al.  Cross-contamination with tamoxifen induces transgene expression in non-exposed inducible transgenic mice. , 2004 .

[7]  A. McMahon,et al.  Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase , 1998, Current Biology.

[8]  M Aguet,et al.  Inducible gene targeting in mice , 1995, Science.

[9]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[10]  P Chambon,et al.  Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. , 1997, Biochemical and biophysical research communications.

[11]  F. Guillou,et al.  Mammalian genome targeting using site-specific recombinases. , 2006, Frontiers in bioscience : a journal and virtual library.

[12]  P. Hirsimäki,et al.  Toxicity of Antiestrogens , 2002, The breast journal.

[13]  A. Bradley,et al.  Tools for targeted manipulation of the mouse genome. , 2002, Physiological genomics.

[14]  Caiying Guo,et al.  A cre recombinase transgene with mosaic, widespread tamoxifen‐inducible action , 2002, Genesis.

[15]  D. Livingston,et al.  Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. , 2001, Molecular cell.

[16]  Hung-Shu Chang,et al.  Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown. , 2004, The American journal of pathology.

[17]  Richard Kemp,et al.  Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity. , 2004, Nucleic acids research.

[18]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[19]  M. Capecchi,et al.  Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Andrew P McMahon,et al.  Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. , 2002, Developmental biology.

[21]  F. Alt,et al.  Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. , 2001, Immunity.

[22]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[23]  A. Berns,et al.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.

[24]  Rudolf Jaenisch,et al.  Rapid generation of inducible mouse mutants. , 2003, Nucleic acids research.

[25]  Yoshitsugu Yamada,et al.  Practical Range of Effective Dose for Cre Recombinase‐Expressing Recombinant Adenovirus without Cell Toxicity in Mammalian Cells , 2005, Microbiology and immunology.

[26]  P. Chambon,et al.  A chimeric Cre recombinase inducible by synthetic,but not by natural ligands of the glucocorticoid receptor. , 1998, Nucleic acids research.

[27]  J. Vonesch,et al.  Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Oesch,et al.  RNAi knock-down mice: an emerging technology for post-genomic functional genetics , 2004, Cytogenetic and Genome Research.

[29]  P. Angrand,et al.  Regulation of Cre recombinase activity by the synthetic steroid RU 486. , 1996, Nucleic acids research.

[30]  P. Sharp,et al.  Cre-lox-regulated conditional RNA interference from transgenes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  F. Gage,et al.  Delivery of the Cre recombinase by a self-deleting lentiviral vector: Efficient gene targeting in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  David John Adams,et al.  Are we Creating problems? Negative effects of Cre recombinase , 2001, Genesis.

[33]  X. Coumoul,et al.  RNAi in mice: a promising approach to decipher gene functions in vivo. , 2006, Biochimie.

[34]  J. S. Gutkind,et al.  Conditional Expression of K-ras in an Epithelial Compartment that Includes the Stem Cells Is Sufficient to Promote Squamous Cell Carcinogenesis , 2004, Cancer Research.

[35]  F. Sablitzky,et al.  Inducible site-directed recombination in mouse embryonic stem cells. , 1996, Nucleic acids research.

[36]  R. Sprengel,et al.  Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit–expressing lineage-negative hematopoietic cells , 2006 .

[37]  F. Oesch,et al.  Of mice and models: improved animal models for biomedical research. , 2002, Physiological genomics.

[38]  C. Branda,et al.  Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. , 2004, Developmental cell.

[39]  A. Berns,et al.  Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Barbacid,et al.  Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development. , 2005, Cancer cell.

[41]  P. Chambon,et al.  Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R Kuhn,et al.  Temporally and spatially regulated somatic mutagenesis in mice. , 1998, Nucleic acids research.

[43]  K. Rajewsky,et al.  New variants of inducible Cre recombinase: a novel mutant of Cre-PR fusion protein exhibits enhanced sensitivity and an expanded range of inducibility. , 2001, Nucleic acids research.

[44]  P Chambon,et al.  Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. , 1999, Nucleic acids research.

[45]  Jos Jonkers,et al.  A highly efficient ligand‐regulated Cre recombinase mouse line shows that LoxP recombination is position dependent , 2001, EMBO reports.